Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01601613
Recruitment Status : Completed
First Posted : May 18, 2012
Last Update Posted : January 11, 2017
Information provided by (Responsible Party):
Novo Nordisk A/S